Alumis Inc. (ALMS)
NASDAQ: ALMS · IEX Real-Time Price · USD
12.50
-0.01 (-0.08%)
At close: Jul 19, 2024, 4:00 PM
12.62
+0.12 (0.96%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Alumis Employees
As of December 31, 2023, Alumis had 109 total employees, including 107 full-time and 2 part-time employees.
Employees
109
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$900,073
Market Cap
704.62M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 109 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Weave Communications | 844 |
| Lexicon Pharmaceuticals | 285 |
| Zymeworks | 278 |
| Wave Life Sciences | 268 |
| Scholar Rock Holding | 150 |
| CARGO Therapeutics | 116 |
| Stoke Therapeutics | 110 |
| Arbutus Biopharma | 73 |
ALMS News
- 23 days ago - Immune Disease-Focused Alumis Raises $250M In Downsized Initial Public Offering - Benzinga
- 23 days ago - Biopharma firm Alumis' shares fall nearly 16% in Nasdaq debut - Reuters
- 24 days ago - Therapy developer Alumis prices U.S. IPO at about $902 mln valuation - Reuters
- 24 days ago - Alumis Announces Pricing of Initial Public Offering - GlobeNewsWire
- 4 weeks ago - Therapy developer Alumis seeks up to $1 bln valuation in US IPO - Reuters
- 4 weeks ago - Alumis eyes $300 million in proceeds in IPO - Market Watch
- 6 weeks ago - Alumis, a biotech focused on immune-mediated diseases, files for a $100 million IPO - Renaissance Capital
- 6 weeks ago - Alumis IPO Registration Document (S-1) - SEC